Stephen Baxter
Stock Analyst at Wells Fargo
(3.90)
# 1,887
Out of 4,495 analysts
670
Total ratings
49.4%
Success rate
4.9%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PNTG The Pennant Group | Rated: Buy | $41 | $40.46 | +1.33% | 10 | Jul 1, 2026 | |
| BTSG BrightSpring Health Services | Rated: Buy | $61 | $71.58 | -14.78% | 21 | Jul 1, 2026 | |
| CNC Centene | Maintained: Hold | $56 | $67.60 | -17.16% | 50 | Jun 4, 2026 | |
| CI The Cigna Group | Maintained: Hold | $305 | $291.80 | +4.52% | 39 | Jun 4, 2026 | |
| CVS CVS Health | Maintained: Buy | $103 | $102.81 | +0.18% | 48 | Jun 4, 2026 | |
| HUM Humana | Maintained: Hold | $227 | $397.76 | -42.93% | 59 | Jun 4, 2026 | |
| MOH Molina Healthcare | Maintained: Hold | $159 | $232.09 | -31.49% | 51 | Jun 4, 2026 | |
| ELV Elevance Health | Maintained: Buy | $391 | $420.39 | -6.99% | 48 | Jun 4, 2026 | |
| OSCR Oscar Health | Upgraded: Hold | $11 → $20 | $31.20 | -35.90% | 31 | Jun 4, 2026 | |
| UHS Universal Health Services | Initiated Coverage: Hold | $212 → $165 | $155.20 | +6.31% | 33 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $331 | $302.46 | +9.44% | 22 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $397 | $431.68 | -8.03% | 50 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $19 | $12.18 | +55.99% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $925 → $812 | $792.81 | +2.42% | 25 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $72 | $115.67 | -37.75% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 | $40.85 | +15.06% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $2 | $3.70 | -45.95% | 28 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $481 → $436 | $409.01 | +6.60% | 30 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $256 | $233.77 | +9.51% | 21 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $265 | $206.77 | +28.16% | 31 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $28 | $31.40 | -10.83% | 10 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $9.21 | -13.14% | 17 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $40 | $9.12 | n/a | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $235 | $277.63 | n/a | 6 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $88 → $91 | $535.50 | n/a | 2 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $116 | $208.05 | n/a | 1 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $203 | $233.60 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $208.97 | n/a | 1 | Nov 14, 2019 |
The Pennant Group
Jul 1, 2026
Rated: Buy
Price Target: $41
Current: $40.46
Upside: +1.33%
BrightSpring Health Services
Jul 1, 2026
Rated: Buy
Price Target: $61
Current: $71.58
Upside: -14.78%
Centene
Jun 4, 2026
Maintained: Hold
Price Target: $56
Current: $67.60
Upside: -17.16%
The Cigna Group
Jun 4, 2026
Maintained: Hold
Price Target: $305
Current: $291.80
Upside: +4.52%
CVS Health
Jun 4, 2026
Maintained: Buy
Price Target: $103
Current: $102.81
Upside: +0.18%
Humana
Jun 4, 2026
Maintained: Hold
Price Target: $227
Current: $397.76
Upside: -42.93%
Molina Healthcare
Jun 4, 2026
Maintained: Hold
Price Target: $159
Current: $232.09
Upside: -31.49%
Elevance Health
Jun 4, 2026
Maintained: Buy
Price Target: $391
Current: $420.39
Upside: -6.99%
Oscar Health
Jun 4, 2026
Upgraded: Hold
Price Target: $11 → $20
Current: $31.20
Upside: -35.90%
Universal Health Services
May 29, 2026
Initiated Coverage: Hold
Price Target: $212 → $165
Current: $155.20
Upside: +6.31%
May 28, 2026
Reiterated: Buy
Price Target: $331
Current: $302.46
Upside: +9.44%
May 20, 2026
Maintained: Buy
Price Target: $397
Current: $431.68
Upside: -8.03%
May 13, 2026
Maintained: Buy
Price Target: $22 → $19
Current: $12.18
Upside: +55.99%
May 12, 2026
Maintained: Hold
Price Target: $925 → $812
Current: $792.81
Upside: +2.42%
May 7, 2026
Maintained: Buy
Price Target: $38 → $72
Current: $115.67
Upside: -37.75%
May 7, 2026
Reiterated: Hold
Price Target: $47
Current: $40.85
Upside: +15.06%
Apr 27, 2026
Rated: Sell
Price Target: $2
Current: $3.70
Upside: -45.95%
Apr 27, 2026
Rated: Hold
Price Target: $481 → $436
Current: $409.01
Upside: +6.60%
Apr 13, 2026
Rated: Buy
Price Target: $256
Current: $233.77
Upside: +9.51%
Apr 13, 2026
Rated: Buy
Price Target: $265
Current: $206.77
Upside: +28.16%
Mar 5, 2026
Maintained: Buy
Price Target: $25 → $28
Current: $31.40
Upside: -10.83%
Oct 29, 2025
Maintained: Hold
Price Target: $8
Current: $9.21
Upside: -13.14%
May 1, 2024
Maintained: Hold
Price Target: $4 → $40
Current: $9.12
Upside: n/a
Jan 11, 2021
Downgraded: Hold
Price Target: $235
Current: $277.63
Upside: n/a
May 13, 2020
Downgraded: Hold
Price Target: $88 → $91
Current: $535.50
Upside: n/a
Apr 27, 2020
Upgraded: Hold
Price Target: $116
Current: $208.05
Upside: n/a
Feb 18, 2020
Upgraded: Buy
Price Target: $203
Current: $233.60
Upside: n/a
Nov 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $208.97
Upside: n/a